Detection of 11 germline inactivating TP53 mutations and absence of TP63 and HCHK2 mutations in 17 French families with Li-Fraumeni or Li-Fraumeni-like syndrome

被引:46
作者
Bougeard, G
Limacher, JM
Martin, C
Charbonnier, F
Killian, A
Delattre, O
Longy, M
Jonveaux, P
Fricker, JP
Stoppa-Lyonnet, D
Flaman, JM
Frébourg, T
机构
[1] Fac Med & Pharm, INSERM, F-76183 Rouen, France
[2] IFRMP, F-76821 Mont St Aignan, France
[3] Hop Univ, F-67091 Strasbourg, France
[4] Inst Curie, Serv Genet Oncol, F-75248 Paris, France
[5] Inst Bergonie, F-33076 Bordeaux, France
[6] CHU Nancy, Hop Brabois, Genet Lab, F-54511 Vandoeuvre Les Nancy, France
[7] Ctr Paul Strauss, F-67085 Strasbourg, France
关键词
D O I
10.1136/jmg.38.4.253
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
引用
收藏
页码:253 / 256
页数:4
相关论文
共 24 条
  • [1] Cloning and chromosomal mapping of the human p53-related KET gene to Chromosome 3q27 and its murine homolog Ket to mouse Chromosome 16
    Augustin, M
    Bamberger, C
    Paul, D
    Schmale, H
    [J]. MAMMALIAN GENOME, 1998, 9 (11) : 899 - 902
  • [2] Heterozygous germ line hCHK2 mutations in Li-Fraumeni syndrome
    Bell, DW
    Varley, JM
    Szydlo, TE
    Kang, DH
    Wahrer, DCR
    Shannon, KE
    Lubratovich, M
    Verselis, SJ
    Isselbacher, KJ
    Fraumeni, JF
    Birch, JM
    Li, FP
    Garber, JE
    Haber, DA
    [J]. SCIENCE, 1999, 286 (5449) : 2528 - 2531
  • [3] BIRCH JM, 1994, CANCER RES, V54, P1298
  • [4] Heterozygous germline mutations in the p53 homolog p63 are the cause of EEC syndrome
    Celli, J
    Duijf, P
    Hamel, BCJ
    Bamshad, M
    Kramer, B
    Smits, APT
    Newbury-Ecob, R
    Hennekam, RCM
    Van Buggenhout, G
    van Haeringen, B
    Woods, CG
    van Essen, AJ
    de Waal, R
    Vriend, G
    Haber, DA
    Yang, A
    McKeon, F
    Brunner, HG
    van Bokhoven, H
    [J]. CELL, 1999, 99 (02) : 143 - 153
  • [5] Mammalian Chk2 is a downstream effector of the ATM-dependent DNA damage checkpoint pathway
    Chaturvedi, P
    Eng, WK
    Zhu, Y
    Mattern, MR
    Mishra, R
    Hurle, MR
    Zhang, XL
    Annan, RS
    Lu, Q
    Faucette, LF
    Scott, GF
    Li, XT
    Carr, SA
    Johnson, RK
    Winkler, JD
    Zhou, BBS
    [J]. ONCOGENE, 1999, 18 (28) : 4047 - 4054
  • [6] Chehab NH, 2000, GENE DEV, V14, P278
  • [7] Eeles RA, 1995, CANCER SURV, V25, P101
  • [8] Identification of human p53 mutations with differential effects on the bax and p21 promoters using functional assays in yeast
    Flaman, JM
    Robert, V
    Lenglet, S
    Moreau, V
    Iggo, R
    Frebourg, T
    [J]. ONCOGENE, 1998, 16 (10) : 1369 - 1372
  • [9] A SIMPLE P53 FUNCTIONAL ASSAY FOR SCREENING CELL-LINES, BLOOD, AND TUMORS
    FLAMAN, JM
    FREBOURG, T
    MOREAU, V
    CHARBONNIER, F
    MARTIN, C
    CHAPPUIS, P
    SAPPINO, AP
    LIMACHER, JM
    BRON, L
    BENHATTAR, J
    TADA, M
    VAN MEIR, EG
    ESTREICHER, A
    IGGO, RD
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (09) : 3963 - 3967
  • [10] A RAPID PCR FIDELITY ASSAY
    FLAMAN, JM
    FREBOURG, T
    MOREAU, V
    CHARBONNIER, F
    MARTIN, C
    ISHIOKA, C
    FRIEND, SH
    IGGO, R
    [J]. NUCLEIC ACIDS RESEARCH, 1994, 22 (15) : 3259 - 3260